Novartis Pharma migrates another site to the latest V3 PAS-X version by Werum
Lüneburg, Germany, July 10, 2015 – Novartis Pharma successfully migrated the Irish production site in Ringaskiddy near Cork to the latest V3 PAS-X version by Werum. This division of Novartis produces important active pharmaceutical ingredients for the production of Novartis' patent-protected prescription drugs.
After three years of managing production processes with PAS-X, Ringaskiddy migrated to the latest PAS-X version. The technological and functional improvements of the new V3 version allow the site to speed up operation processes and increase efficiency. PAS-X is run as a full-blown MES in the whole plant.
"Supported by PAS-X, we can significantly expedite batch release processes and reliable warehouse management is now much easier to ensure", says Alan Daly, Automation Support, Novartis Pharma. "It was a pleasure to work with Werum's highly professional team and we look forward to collaborating again on future projects."
At the Cork site, Novartis Pharma for the first time implemented PAS-X with a standardized interface to SAP MII. This interface will become an integral element of all PAS-X systems at Novartis Pharma.